Schedule 13G ownership disclosure
HEPION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 426897104
Event date: 2021-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,000,000
- Percent of class
- 6.5600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-21-000079
- Form type
- SC 13G
- Filer
- Hepion Pharmaceuticals, Inc.
- CIK
- CIK 1583771
- Filed
- Feb 19, 2021
- Reporting period
- Feb 16, 2021
- Description
- Schedule 13G beneficial ownership